IO360° Team and BioPharm Insight Co-Present Immuno-Oncology KOL Panel During the 35th Annual J.P. Morgan Healthcare Conference Week

Share Article

The IO360° team at the Conference Forum are delighted to collaborate for the first time with BioPharm Insight in presenting an in-depth panel to filter the hype in immuno-oncology for the next wave of targets during the 35th annual J.P. Morgan Healthcare Conference week.

News Image
“With our experience in producing the Immuno-Oncology 360° NYC event, it was a natural fit to collaborate with BIOPHARM INSIGHT on co-developing the Immuno-Oncology: Filtering the Hype panel," said Valerie Bowling, Executive Director, The Conference Forum

The Conference Forum announced that the IO360° team is collaborating for the first time with BioPharm Insight to co-present a panel discussion on "Immuno-Oncology: Filtering the Hype for the Next Wave of Targets" at the same time as the 35th annual J.P. Morgan Healthcare Conference. The panel discussion will take place on January 9, 2017 at the Chandaran Art Gallery in San Francisco. Following the discussion, a networking reception will be open to registered attendees starting at 6:30pm.

“With our experience in producing the Immuno-Oncology 360° NYC event, it was a natural fit to collaborate with BioPharm Insight on co-developing the 'Immuno-Oncology: Filtering the Hype' panel," said Valerie Bowling, Executive Director, The Conference Forum

The panel features key opinion leaders (KOLs) and industry experts to address timely issues in the immuno-oncology field including, but not limited to, next-generation I/O therapeutics, check point inhibitors, combinations, pricing and reimbursement expectations, and more.

Panelists include:

  • Axel Hoos, MD, PhD, SVP Oncology R&D, GSK and Co-Chair for IO360°
  • Ira Mellman, PhD, VP Cancer Immunology, Genentech
  • Lindee Goh, Partner, Tapestry Networks
  • Omid Hamid, MD, Chief, Translational Research and Immunotherapy / Director, Melanoma Therapeutics, The Angeles Clinic
  • Ramy Ibrahim, MD, VP and Head of R&D, Parker Institute for Cancer Immunotherapy

The panel is moderated by Querida Anderson, Editor-in-Chief at BioPharm Insight.

Venue Information:
Chandaran Art Gallery
459 Geary Street
San Francisco, CA 94102

The panel and reception are complimentary, but there is limited seating. For more information, please go to:
http://www.biopharminsight.com/events/biopharm-insight-exclusive-event

About IO360°
The IO360° team at the Conference Forum works with lead advisors in immuno-oncology to present a program with a multiple perspectives to address the business aspects, clinical advancements and scientific data that will help accelerate the way cancer is treated. IO360° takes place in NYC on February 1-3, 2017. For more information, click here.

About BioPharm Insight
BioPharm Insight is a comprehensive life science market intelligence and analytics solution. With thousands of aggregated datasets and a global team of investigative journalists, BioPharm Insight is a central source of information. Please click here for their website.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Onalee Smith
The Conference Forum LLC
+1 (646) 350-2580 Ext: 308
Email >
@ConferenceForum
Follow >
The Conference Forum
Like >
The Conference Forum

Visit website